Inventor · Berlin, DE

Simon Holton

20Patents
3h-index
81Co-inventors
62Inventor score

Filing activity: Nov 17, 2010 → Dec 30, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US9643953B2 Substituted benzylpyrazoles Chemistry; Metallurgy 4 Active
US9682974B2 Heteroaryl substituted pyrazoles Chemistry; Metallurgy 4 Active
US9765058B2 Substituted benzylpyrazoles Human Necessities 3 Active
US9745285B2 Heteroaryl substituted pyrazoles Chemistry; Metallurgy 3 Active
US10584167B2 Anti-CEACAM6 antibodies and uses thereof Chemistry; Metallurgy 2 Active
US10350206B2 Benzyl substituted indazoles as BUB1 inhibitors Chemistry; Metallurgy 1 Active
US8551980B2 Substituted triazolopyridines Human Necessities 1 Active
US10266548B2 Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases Chemistry; Metallurgy 1 Active
US11866495B2 Anti-CEACAM6 antibodies and uses thereof Chemistry; Metallurgy 0 Active
US9422268B2 Substituted benzylpyrazoles General 0 Revoked
US10604532B2 Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases Chemistry; Metallurgy 0 Active
US10428044B2 3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones Chemistry; Metallurgy 0 Active
US9555022B2 Substituted triazolopyridines Chemistry; Metallurgy 0 Active
US11773164B2 Anti-CEACAM6 antibodies and uses thereof Chemistry; Metallurgy 0 Active
US9884063B2 Amido-substituted azole compounds Chemistry; Metallurgy 0 Active
US9676766B2 Triazolopyridines Human Necessities 0 Active
US9265763B2 Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases General 0 Revoked
US9416125B2 Substituted cycloalkenopyrazoles as BUB1 inhibitors for the treatment of cancer General 0 Revoked
US11667675B2 MASP inhibitory compounds and uses thereof Human Necessities 0 Active
US9260412B2 Substituted benzylpyrazoles General 0 Revoked

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.